The Charles Bronfman Institute for Personalized Medicine brings together a group of experts in the clinical and biological data sciences committed to exploring the nature of human disease through cohort studies. We carry out these studies at scale in clinics, emergency rooms, and inpatient units within the Mount Sinai Health System. 

The institute collaboratively and rapidly translates key discoveries into experimental interventions and new standards of care. We aim to position Mount Sinai at the forefront of data-driven clinical care by creating a landscape where every patient can be a research participant, clinical decisions are data-driven, and care is continuously optimized. 

Mount Sinai Million Health Discoveries Program 

Institute leadership has special experience in designing and executing challenging, high-impact cohort studies embedded into the daily flow of clinical care. Building on this experience, we are launching the Mount Sinai Million Health Discoveries Program, a real-world genetic cohort study of one million Mount Sinai patients. 

This study will yield fundamental discoveries that our researchers will be able to translate into experimental interventions and new treatment guidelines. Our goal is to develop standards of rigor for incorporating predictive models into clinical care.